摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-Nitro-5-piperazin-1-yl-2-trifluoromethyl-phenyl)-piperidine-4-carboxylic acid ethyl ester | 677026-70-9

中文名称
——
中文别名
——
英文名称
1-(4-Nitro-5-piperazin-1-yl-2-trifluoromethyl-phenyl)-piperidine-4-carboxylic acid ethyl ester
英文别名
——
1-(4-Nitro-5-piperazin-1-yl-2-trifluoromethyl-phenyl)-piperidine-4-carboxylic acid ethyl ester化学式
CAS
677026-70-9
化学式
C19H25F3N4O4
mdl
——
分子量
430.427
InChiKey
RFQNGWXTQBKFAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    30.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    87.95
  • 氢给体数:
    1.0
  • 氢受体数:
    7.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-Nitro-5-piperazin-1-yl-2-trifluoromethyl-phenyl)-piperidine-4-carboxylic acid ethyl ester 在 lithium hydroxide 、 N,N-二异丙基乙胺 作用下, 以 四氢呋喃二甲基亚砜 为溶剂, 反应 10.0h, 生成 1-{5-[4-(2,6-Dinitro-3-trifluoromethyl-phenyl)-piperazin-1-yl]-4-nitro-2-trifluoromethyl-phenyl}-piperidine-4-carboxylic acid
    参考文献:
    名称:
    Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
    摘要:
    Compound 2 was identified by high throughput screening as a novel PAI-1 inhibitor. Systematic optimization of the A, B, and C segments of 2 resulted in the identification of a more potent compound 39 with good oral bioavailability. The synthesis and SAR data are presented in this report. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.11.035
  • 作为产物:
    参考文献:
    名称:
    Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
    摘要:
    Compound 2 was identified by high throughput screening as a novel PAI-1 inhibitor. Systematic optimization of the A, B, and C segments of 2 resulted in the identification of a more potent compound 39 with good oral bioavailability. The synthesis and SAR data are presented in this report. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.11.035
点击查看最新优质反应信息